SpringWorks Therapeutics Inc (SWTX)
Has a drug that the FDA will be making an announcement about on Mon Nov 27. One week from today. (Thanksgiving-closed, Friday-short day, Monday-the stock may trade on announcement day, it may not.)
The FDA has considered this drug for approval before, but made no determination, and it said it would look further at the existing data ( didn't ask for new data)
My doctor friend thinks the announcement on 11/27 will be approval with conditions. Not for (was it?) women of childbearing age. Yet they're the ones who often get the illness this drug is treating.
The stock is very volatile. We're thinking a jump on it's approval followed by a cooling off period when people wonder how big the market really is.